Concepedia

Author

Ulrich Germing

Heinrich Heine University Düsseldorf

Also Known As

Boris Labar, Germing U., Germing, U, María Díez-Campelo, U GERMING, U Germing, U. Germing, Ulrich Germing

602

Publications

22.1K

Citations

61

H-Index

120

Concepts

All Affiliations

Heinrich Heine University DüsseldorfDüsseldorf University HospitalUniversité Paris CitéUniversity of PaviaIstituti di Ricovero e Cura a Carattere Scientifico
UG

About

Ulrich Germing is an author at Heinrich Heine University Düsseldorf specializing in medicine, hematology, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

26

52

4.2K

2

Health Sciences

11

11

503

3

Public Health

6

6

1K

4

Biostatistics

3

3

798

5

Engineering

1

1

16

Ulrich Germing

×

140

Publications

16.2K

Citations

51

H-Index

YearCitations

Revised International Prognostic Scoring System for Myelodysplastic Syndromes

Peter L. Greenberg, Heinz Tuechler, Julie Schanz,

Blood

2012

3.1K

Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia

Pierre Fenaux, Ghulam J. Mufti, Eva Hellström‐Lindberg,

Journal of Clinical Oncology

2009

951

<i>IDH1</i>and<i>IDH2</i>Mutations Are Frequent Genetic Alterations in Acute Myeloid Leukemia and Confer Adverse Prognosis in Cytogenetically Normal Acute Myeloid Leukemia With<i>NPM1</i>Mutation Without<i>FLT3</i>Internal Tandem Duplication

Peter Paschka, Richard F. Schlenk, Verena I. Gaidzik,

Journal of Clinical Oncology

2010

784

New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients

Detlef Haase, Ulrich Germing, Julie Schanz,

Blood

2007

783

Molecular International Prognostic Scoring System for Myelodysplastic Syndromes

Elsa Bernard, Heinz Tuechler, Peter L. Greenberg,

NEJM Evidence

2022

746

Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet

Luca Malcovati, Eva Hellström‐Lindberg, David Bowen,

Blood

2013

663

Human Immunoglobulin M Memory B Cells Controlling <i>Streptococcus pneumoniae</i> Infections Are Generated in the Spleen

Stephanie Kruetzmann, Maria Manuela Rosado, Holger Weber,

The Journal of Experimental Medicine

2003

619

Low-Dose Decitabine Versus Best Supportive Care in Elderly Patients With Intermediate- or High-Risk Myelodysplastic Syndrome (MDS) Ineligible for Intensive Chemotherapy: Final Results of the Randomized Phase III Study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDS Study Group

Michael Lübbert, Stefan Suciu, Liliana Baila,

Journal of Clinical Oncology

2011

546

Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes

Pierre Fenaux, Uwe Platzbecker, Ghulam J. Mufti,

New England Journal of Medicine

2020

519

Monitoring of Minimal Residual Disease in <i>NPM1</i> -Mutated Acute Myeloid Leukemia: A Study From the German-Austrian Acute Myeloid Leukemia Study Group

Jan Krönke, Richard F. Schlenk, Kai‐Ole Jensen,

Journal of Clinical Oncology

2011

388

Page 1